Literature DB >> 22910100

High endogenous melatonin levels in critically ill children: a pilot study.

Lucia Marseglia1, Salvatore Aversa, Ignazio Barberi, Carmelo D Salpietro, Erika Cusumano, Antonio Speciale, Antonella Saija, Carmelo Romeo, Giuseppe Trimarchi, Russel J Reiter, Eloisa Gitto.   

Abstract

OBJECTIVE: To evaluate the serum melatonin levels in critically ill pediatric patients and to test the effect of light on the melatonin's circadian rhythm. Data on melatonin secretion in critically ill pediatric subjects are lacking. STUDY
DESIGN: We investigated the serum melatonin levels of 16 sedated and mechanically ventilated patients in a pediatric intensive care unit. Children (mean age, 5.1 ± 3.1 years) were randomly assigned to a dark-exposed or to a light-exposed group to evaluate the effects of light on serum melatonin concentrations. Blood samples for serum melatonin analysis were collected at 10 p.m., 1 a.m., 3 a.m., 5 a.m., 8 a.m., and 12 p.m.
RESULTS: The melatonin circadian rhythm was severely disrupted in critically ill children; light exposure lowered serum melatonin even in a context of highly altered circadian cycle; melatonin peaks were greater for healthy age-matched children.
CONCLUSION: The high melatonin levels in the critically ill children may be a response to counteract the elevated oxidative stress associated with serious diseases. Whether these elevated melatonin levels confer any beneficial effects in pediatric critically ill patients remains unknown.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22910100     DOI: 10.1016/j.jpeds.2012.07.019

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  12 in total

1.  Untargeted metabolomic analysis and pathway discovery in perinatal asphyxia and hypoxic-ischaemic encephalopathy.

Authors:  Niamh M Denihan; Jennifer A Kirwan; Brian H Walsh; Warwick B Dunn; David I Broadhurst; Geraldine B Boylan; Deirdre M Murray
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-25       Impact factor: 6.200

2.  Premedication with melatonin vs midazolam: efficacy on anxiety and compliance in paediatric surgical patients.

Authors:  Pietro Impellizzeri; Enrica Vinci; Maria Cristina Gugliandolo; Francesca Cuzzocrea; Rosalba Larcan; Tiziana Russo; Maria Rosaria Gravina; Salvatore Arena; Gabriella D'Angelo; Eloisa Gitto; Angela Simona Montalto; Angela Alibrandi; Lucia Marseglia; Carmelo Romeo
Journal:  Eur J Pediatr       Date:  2017-05-24       Impact factor: 3.183

3.  Relationship between circadian activity rhythms and fatigue in hospitalized children with CNS cancers receiving high-dose chemotherapy.

Authors:  Valerie E Rogers; Shijun Zhu; Belinda N Mandrell; Sonia Ancoli-Israel; Lianqi Liu; Pamela S Hinds
Journal:  Support Care Cancer       Date:  2019-07-04       Impact factor: 3.603

4.  Effect of a light-darkness cycle on the body weight gain of preterm infants admitted to the neonatal intensive care unit.

Authors:  Manuel Sánchez-Sánchez; Teodoro L García; Donají Heredia; Isaac Reséndiz; Lorena Cruz; Jacqueline Santiago; Adelina Rojas-Granados; Laura Ubaldo-Reyes; Laura Pérez-Campos-Mayoral; Eduardo Pérez-Campos; Gervacio S Vásquez; Juan M Moguel; Romeo Zarate; Oscar García; Luisa Sánchez; Fernando Torres; Alberto Paz; Jesús Elizarraras-Rivas; María T Hernández-Huerta; Manuel Angeles-Castellanos
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

5.  Evaluation of Melatonin Practices for Delirium in Pediatric Critically Ill Patients.

Authors:  Thomas W Laudone; Shawna D Beck; Hubert J Lahr
Journal:  J Pediatr Pharmacol Ther       Date:  2021-05-19

Review 6.  New horizons for newborn brain protection: enhancing endogenous neuroprotection.

Authors:  K Jane Hassell; Mojgan Ezzati; Daniel Alonso-Alconada; Derek J Hausenloy; Nicola J Robertson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2015-06-10       Impact factor: 5.747

Review 7.  Melatonin as a Potential Agent in the Treatment of Sarcopenia.

Authors:  Ana Coto-Montes; Jose A Boga; Dun X Tan; Russel J Reiter
Journal:  Int J Mol Sci       Date:  2016-10-24       Impact factor: 5.923

8.  Melatonin in the management of perinatal hypoxic-ischemic encephalopathy: light at the end of the tunnel?

Authors:  Mohamed A Hendaus; Fatima A Jomha; Ahmed H Alhammadi
Journal:  Neuropsychiatr Dis Treat       Date:  2016-09-27       Impact factor: 2.570

Review 9.  Protective role of melatonin in neonatal diseases.

Authors:  Eloisa Gitto; Lucia Marseglia; Sara Manti; Gabriella D'Angelo; Ignazio Barberi; Carmelo Salpietro; Russel J Reiter
Journal:  Oxid Med Cell Longev       Date:  2013-11-19       Impact factor: 6.543

10.  Hepatic Macrosteatosis Is Partially Converted to Microsteatosis by Melatonin Supplementation in ob/ob Mice Non-Alcoholic Fatty Liver Disease.

Authors:  Alessandra Stacchiotti; Gaia Favero; Antonio Lavazza; Igor Golic; Marija Aleksic; Aleksandra Korac; Luigi Fabrizio Rodella; Rita Rezzani
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.